TC
SPPI

TFS Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

TFS Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-97,526
Closed -$727K – 414
2017
Q2 		$727K Buy
+97,526
New +$637K 0.28% 118
2016
Q3 		– Sell
-51,438
Closed -$338K – 1044
2016
Q2 		$338K Buy
+51,438
New +$363K 0.06% 552
2015
Q4 		– Sell
-286,105
Closed -$1.71M – 945
2015
Q3 		$1.71M Buy
+286,105
New +$1.99M 0.17% 196
2015
Q2 		– Sell
-186,397
Closed -$1.13M – 1125
2015
Q1 		$1.13M Sell
186,397
-7,887
-4% -$52.5K 0.11% 301
2014
Q4 		$1.35M Buy
194,284
+81,939
+73% +$603K 0.13% 241
2014
Q3 		$914K Buy
+112,345
New +$879K 0.08% 402

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TFS Capital's SPPI Position: Q3 2017 in Review

TFS Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2017, closing a stake of 97,526 shares — an estimated $727K sold.

TFS Capital first reported a position in SPPI in Q3 2014 and held it in 6 quarters. The position peaked at $1.71M in Q3 2015. 158 funds tracked by Wall St. Rank hold SPPI as of Q3 2017.

  • TFS Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 97,526 Spectrum Pharmaceuticals Inc shares in Q3 2017, an estimated $727K.
  • TFS Capital first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 6 quarters.
  • TFS Capital's Spectrum Pharmaceuticals Inc position peaked at $1.71M in Q3 2015.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.